BioTelemetry Company Profile (NASDAQ:BEAT)

About BioTelemetry

BioTelemetry logoBioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segment's principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting. The product business segment focuses on the development, manufacturing, testing and marketing of medical devices to medical companies, clinics and hospitals. The Company's research services focuses on providing cardiac safety monitoring services for drug and medical treatment trials in a research environment. In August 2012, the Company completed the acquisition of Cardiocore Lab, Inc. (Cardiocore).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BEAT
  • CUSIP:
Key Metrics:
  • Previous Close: $18.55
  • 50 Day Moving Average: $18.76
  • 200 Day Moving Average: $17.06
  • 52-Week Range: $8.74 - $21.68
  • Trailing P/E Ratio: 39.15
  • Foreward P/E Ratio: 22.08
  • P/E Growth: 0.00
  • Market Cap: $515.66M
  • Outstanding Shares: 28,025,000
  • Beta: 0.73
  • Net Margins: 7.11%
  • Return on Equity: 25.36%
  • Return on Assets: 15.10%
  • Debt-to-Equity Ratio: 0.41%
  • Current Ratio: 2.07%
  • Quick Ratio: 1.94%
Additional Links:
Companies Related to BioTelemetry:

Analyst Ratings

Consensus Ratings for BioTelemetry (NASDAQ:BEAT) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.33 (36.57% upside)

Analysts' Ratings History for BioTelemetry (NASDAQ:BEAT)
DateFirmActionRatingPrice TargetDetails
10/5/2016Lake Street CapitalReiterated RatingBuy$24.00View Rating Details
9/13/2016SidotiInitiated CoverageBuy$27.00View Rating Details
8/3/2016Benchmark Co.Boost Price TargetBuy$20.00 -> $25.00View Rating Details
7/28/2015Dougherty & CoBoost Price TargetBuy$18.00 -> $20.00View Rating Details
11/24/2014Avondale PartnersUpgradeMarket Perform -> OutperformView Rating Details
(Data available from 10/21/2014 forward)


Earnings History for BioTelemetry (NASDAQ:BEAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q2$0.17$0.20$50.27 million$52.68 millionViewListenView Earnings Details
4/26/2016Q1$0.10$0.20$46.54 million$48.60 millionViewListenView Earnings Details
2/17/2016Q415$0.11$0.15$45.89 million$46.70 millionViewListenView Earnings Details
11/9/2015Q3$0.11$0.13$46.05 million$43.49 millionViewN/AView Earnings Details
8/6/2015Q2$0.09$0.12$45.75 million$44.81 millionViewListenView Earnings Details
5/6/2015Q115$0.02$0.06$43.80 million$43.40 millionViewListenView Earnings Details
2/19/2015Q414$0.06$0.05$43.40 million$43.70 millionViewListenView Earnings Details
10/30/2014Q214$0.02$0.06$42.00 million$43.00 millionViewListenView Earnings Details
7/31/2014Q114$0.01$0.02$40.95 million$42.70 millionViewListenView Earnings Details
5/6/2014Q413($0.02)($0.04)$38.40 million$37.16 millionViewListenView Earnings Details
2/26/2014Q313($0.04)$0.05$32.26 million$33.10 millionViewListenView Earnings Details
11/5/2013($0.05)($0.12)$32.79 million$31.90 millionViewListenView Earnings Details
7/30/2013Q2 2013$0.02$27.50 million$32.10 millionViewListenView Earnings Details
2/13/2013Q4 2012($0.09)$26.80 million$30.00 millionViewListenView Earnings Details
11/5/2012Q312($0.09)($0.08)$26.49 million$27.00 millionViewN/AView Earnings Details
8/8/2012($0.04)($0.01)ViewN/AView Earnings Details
5/8/2012($0.12)($0.10)ViewN/AView Earnings Details
2/22/2012($0.13)($0.04)ViewN/AView Earnings Details
11/8/2011($0.09)($0.21)ViewN/AView Earnings Details
8/8/2011($0.06)($0.05)ViewN/AView Earnings Details
5/3/2011($0.15)($0.02)ViewN/AView Earnings Details
2/17/2011($0.16)($0.13)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for BioTelemetry (NASDAQ:BEAT)
Current Year EPS Consensus Estimate: $0.75 EPS
Next Year EPS Consensus Estimate: $0.84 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.08$0.09$0.09
Q2 20161$0.16$0.16$0.16
Q3 20161$0.16$0.16$0.16
Q4 20161$0.16$0.16$0.16
Q1 20171$0.21$0.21$0.21
Q2 20171$0.20$0.20$0.20
Q3 20171$0.20$0.20$0.20
Q4 20171$0.22$0.22$0.22
(Data provided by Zacks Investment Research)


Dividend History for BioTelemetry (NASDAQ:BEAT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for BioTelemetry (NASDAQ:BEAT)
Insider Ownership Percentage: 11.00%
Institutional Ownership Percentage: 78.26%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/19/2016George HrenkoSVPSell1,061$18.50$19,628.50View SEC Filing  
9/13/2016Heather C GetzCFOSell5,866$18.23$106,937.18View SEC Filing  
9/13/2016Joseph H CapperInsiderSell26,847$18.23$489,420.81View SEC Filing  
9/13/2016Peter FerolaGeneral CounselSell4,352$18.23$79,336.96View SEC Filing  
9/9/2016Fred BroadwaySVPSell3,146$17.84$56,124.64View SEC Filing  
9/8/2016George HrenkoSVPSell3,491$18.06$63,047.46View SEC Filing  
9/8/2016Heather C GetzCFOSell2,979$18.10$53,919.90View SEC Filing  
9/8/2016Joseph H CapperInsiderSell13,632$18.10$246,739.20View SEC Filing  
9/8/2016Peter FerolaGeneral CounselSell2,210$18.10$40,001.00View SEC Filing  
9/7/2016Daniel WisniewskiSVPSell9,225$18.51$170,754.75View SEC Filing  
9/7/2016Heather C GetzCFOSell18,945$18.52$350,861.40View SEC Filing  
9/7/2016Joseph H CapperInsiderSell86,681$18.52$1,605,332.12View SEC Filing  
9/7/2016Peter FerolaGeneral CounselSell14,053$18.52$260,261.56View SEC Filing  
9/6/2016Fred BroadwaySVPSell4,662$18.28$85,221.36View SEC Filing  
9/6/2016Heather C GetzCFOSell6,686$18.29$122,286.94View SEC Filing  
9/6/2016Joseph H CapperCEOSell30,595$18.29$559,582.55View SEC Filing  
9/6/2016Peter FerolaGeneral CounselSell4,960$18.29$90,718.40View SEC Filing  
9/2/2016Fred BroadwaySVPSell4,466$18.75$83,737.50View SEC Filing  
9/2/2016Heather C GetzCFOSell6,547$18.75$122,756.25View SEC Filing  
9/2/2016Joseph H CapperCEOSell29,953$18.75$561,618.75View SEC Filing  
9/2/2016Peter FerolaGeneral CounselSell4,856$18.75$91,050.00View SEC Filing  
9/1/2016Fred BroadwaySVPSell7,525$19.25$144,856.25View SEC Filing  
9/1/2016Heather C GetzCFOSell10,408$18.59$193,484.72View SEC Filing  
9/1/2016Joseph H CapperInsiderSell47,622$18.59$885,292.98View SEC Filing  
9/1/2016Peter FerolaGeneral CounselSell7,722$18.59$143,551.98View SEC Filing  
8/30/2016Fred BroadwaySVPSell12,121$19.07$231,147.47View SEC Filing  
8/30/2016Heather C GetzCFOSell17,482$19.07$333,381.74View SEC Filing  
8/30/2016Joseph H CapperInsiderSell79,986$19.07$1,525,333.02View SEC Filing  
8/30/2016Peter FerolaGeneral CounselSell12,970$19.07$247,337.90View SEC Filing  
8/25/2016Fred BroadwaySVPSell5,877$19.16$112,603.32View SEC Filing  
8/25/2016Heather C GetzCFOSell8,477$19.16$162,419.32View SEC Filing  
8/25/2016Joseph H CapperInsiderSell38,785$19.16$743,120.60View SEC Filing  
8/25/2016Peter FerolaGeneral CounselSell6,289$19.16$120,497.24View SEC Filing  
8/24/2016George HrenkoSVPSell7,473$20.11$150,282.03View SEC Filing  
8/24/2016Heather C GetzCFOSell8,778$20.11$176,525.58View SEC Filing  
8/24/2016Joseph H CapperCEOSell40,160$20.11$807,617.60View SEC Filing  
8/24/2016Peter FerolaGeneral CounselSell6,512$20.11$130,956.32View SEC Filing  
8/23/2016George HrenkoSVPSell3,165$20.67$65,420.55View SEC Filing  
8/23/2016Heather C GetzCFOSell3,717$20.67$76,830.39View SEC Filing  
8/23/2016Joseph H CapperCEOSell17,008$20.67$351,555.36View SEC Filing  
8/23/2016Peter FerolaGeneral CounselSell2,758$20.67$57,007.86View SEC Filing  
8/22/2016George HrenkoSVPSell4,149$20.85$86,506.65View SEC Filing  
8/22/2016Heather C GetzCFOSell4,874$20.85$101,622.90View SEC Filing  
8/22/2016Joseph H CapperCEOSell22,298$20.85$464,913.30View SEC Filing  
8/22/2016Peter FerolaGeneral CounselSell3,616$20.85$75,393.60View SEC Filing  
8/19/2016Daniel WisniewskiSVPSell9,025$20.96$189,164.00View SEC Filing  
8/19/2016Heather C GetzCFOSell9,026$20.96$189,184.96View SEC Filing  
8/19/2016Joseph H CapperInsiderSell9,049$20.96$189,667.04View SEC Filing  
8/19/2016Peter FerolaGeneral CounselSell9,035$20.96$189,373.60View SEC Filing  
5/9/2014Ronald AhrensDirectorBuy6,000$7.37$44,220.00View SEC Filing  
11/12/2013Ronald AhrensDirectorBuy5,000$11.73$58,650.00View SEC Filing  
11/12/2012Ronald A AhrensDirectorBuy15,000$2.22$33,300.00View SEC Filing  
9/5/2012Joseph H CapperCEOBuy23,540$2.25$52,965.00View SEC Filing  
8/31/2012Joseph H CapperCEOBuy2,600$2.28$5,928.00View SEC Filing  
8/29/2012Joseph H CapperCEOBuy10,800$2.30$24,840.00View SEC Filing  
8/28/2012Joseph H CapperCEOBuy1,300$2.19$2,847.00View SEC Filing  
8/27/2012Joseph H CapperCEOBuy1,600$2.12$3,392.00View SEC Filing  
8/23/2012Joseph H CapperCEOBuy9,600$2.08$19,968.00View SEC Filing  
8/20/2012Joseph H CapperCEOBuy14,160$1.97$27,895.20View SEC Filing  
8/17/2012Joseph H CapperCEOBuy9,800$2.10$20,580.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for BioTelemetry (NASDAQ:BEAT)
News IconNotable Technical Move: Will BioTelemetry, Inc. Short Squeeze Soon? The Stock Formed a Bullish Double Top Chart ... - Chester News (NASDAQ:BEAT) - October 21 at 9:50 AM
News IconHolder Move: Drill Craig A Decreased Its Biotelemetry INC (BEAT) Holding as Stock Rose - Chester News (NASDAQ:BEAT) - October 18 at 8:37 AM
News IconBroker Roundup For BioTelemetry, Inc. (NASDAQ:BEAT) - The De Soto Edge (NASDAQ:BEAT) - October 16 at 8:34 AM
News IconShares Slogging Higher Over the Last Month: BioTelemetry, Inc. (NASDAQ:BEAT) - Recall News (NASDAQ:BEAT) - October 12 at 4:02 PM logoETF’s with exposure to BioTelemetry, Inc. : October 7, 2016 (NASDAQ:BEAT) - October 7 at 3:47 PM logoBioTelemetry, Inc.: Leads amongst peers with strong fundamentals (NASDAQ:BEAT) - October 7 at 8:38 AM
News IconActive Broker's Choice in Focus: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), BioTelemetry, Inc. (NASDAQ:BEAT) - Street Wise Report (press release) (blog) (NASDAQ:BEAT) - October 6 at 3:46 PM logoBioTelemetry, Inc. breached its 50 day moving average in a Bullish Manner : BEAT-US : October 6, 2016 (NASDAQ:BEAT) - October 6 at 8:27 AM
News IconHere's Why BioTelemetry, Inc. Is Soaring Today | Markets-and ... - (NASDAQ:BEAT) - October 5 at 3:31 PM logoAnalyst Update: Catalyst Pharmaceuticals Inc, Applied Optoelectronics Inc, and BioTelemetry, Inc. - Schaeffers Research (blog) (NASDAQ:BEAT) - October 5 at 3:31 PM logoShark Bites: Two Big Movers (NASDAQ:BEAT) - October 5 at 3:31 PM
News IconBroker Changes For BioTelemetry, Inc. (NASDAQ:BEAT) - NewsDen (NASDAQ:BEAT) - October 2 at 3:39 PM logoBioTelemetry, Inc. (NASDAQ:BEAT) :EPS Projection At $0.2 - Investor Newswire (NASDAQ:BEAT) - October 1 at 3:40 PM
News IconNew Analyst Ratings On BioTelemetry, Inc. (NASDAQ:BEAT) - NewsDen (NASDAQ:BEAT) - September 28 at 3:51 PM
News IconFormer Exec Files $15.5M Fraud Suit Against BioTelemetry, Inc (NASDAQ:BEAT) - September 22 at 9:38 AM logoBioTelemetry, Inc. – Value Analysis (NASDAQ:BEAT) : September 19, 2016 (NASDAQ:BEAT) - September 19 at 4:43 PM logoBioTelemetry, Inc. breached its 50 day moving average in a Bullish Manner : BEAT-US : September 16, 2016 (NASDAQ:BEAT) - September 16 at 3:47 PM logoBioTelemetry, Inc. breached its 50 day moving average in a Bullish Manner : BEAT-US : September 16, 2016 (NASDAQ:BEAT) - September 16 at 3:47 PM logoShark Bites: Putting Cash to Work Isn't Easy (NASDAQ:BEAT) - September 15 at 4:17 PM logoCoverage initiated on BioTelemetry by Sidoti (NASDAQ:BEAT) - September 13 at 4:56 PM
News IconShares Slipping Lower Over the Past Month: BioTelemetry, Inc. (NASDAQ:BEAT) - Post News (NASDAQ:BEAT) - September 1 at 3:45 PM logoBioTelemetry, Inc. breached its 50 day moving average in a Bearish Manner : BEAT-US : September 1, 2016 (NASDAQ:BEAT) - September 1 at 12:13 PM logoBioTelemetry, Inc. announces CE mark approval of Holter analysis software - GlobeNewswire (press release) (NASDAQ:BEAT) - August 30 at 3:45 PM logoBioTelemetry : announces CE mark approval of Holter analysis software (NASDAQ:BEAT) - August 30 at 8:47 AM logoBioTelemetry's (BEAT) Holter Analysis Software Receives CE Mark (NASDAQ:BEAT) - August 29 at 9:27 PM logoBioTelemetry, Inc. announces CE mark approval of Holter analysis software (NASDAQ:BEAT) - August 29 at 4:24 PM logoBioTelemetry, Vonage and TPI Composites Have Dipped (NASDAQ:BEAT) - August 25 at 3:50 PM logoShark Bites: BioTelemetry, Vonage and TPI Composites Have Dipped (NASDAQ:BEAT) - August 25 at 3:50 PM logoBioTelemetry (BEAT) to License Technology to Bloomlife (NASDAQ:BEAT) - August 23 at 9:01 PM logoBIOTELEMETRY, INC. Files SEC form 8-K, Other Events (NASDAQ:BEAT) - August 23 at 9:01 PM logoBioTelemetry, Inc. Agrees to License Proprietary Technology to Bloom Technologies, Inc. for Use in Prenatal Market - GlobeNewswire (press release) (NASDAQ:BEAT) - August 23 at 3:49 PM logo8:16 am BioTelemetry enters a strategic partnership with Bloom Technologies (NASDAQ:BEAT) - August 23 at 3:49 PM logoBioTelemetry, Inc. Agrees to License Proprietary Technology to Bloom Technologies, Inc. for Use in Prenatal Market (NASDAQ:BEAT) - August 23 at 3:49 PM
News IconHC Stocks Alerts: BioTelemetry, Inc. (NASDAQ:BEAT) Tokai ... - share market updates (press release) (NASDAQ:BEAT) - August 22 at 3:50 PM logoWill BioTelemetry, Inc. (NASDAQ:BEAT) Hit $25 Price Target? - Investor Newswire (NASDAQ:BEAT) - August 20 at 3:48 PM logoWhy BioTelemetry (BEAT) Could Be Positioned for a Surge? (NASDAQ:BEAT) - August 18 at 12:12 PM logoEdited Transcript of BEAT earnings conference call or presentation 2-Aug-16 9:00pm GMT (NASDAQ:BEAT) - August 16 at 12:31 PM logoBIOTELEMETRY, INC. Financials (NASDAQ:BEAT) - August 11 at 3:53 PM logoBioTelemetry, Inc. :BEAT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:BEAT) - August 10 at 4:10 PM logoIs BioTelemetry (BEAT) Stock a Solid Choice Right Now? (NASDAQ:BEAT) - August 9 at 4:57 PM
News IconAnalysts Remain Strong on BioTelemetry, Inc. (NASDAQ:BEAT ... - Duncan News (NASDAQ:BEAT) - August 6 at 4:11 PM logoAnalysts Update on Stocks: Endo International plc (NASDAQ:ENDP) , BioTelemetry, Inc. (NASDAQ:BEAT) - Street Updates (NASDAQ:BEAT) - August 4 at 3:54 PM logoBioTelemetry Inc. (BEAT) Jumps 6.31% on August 03 - (NASDAQ:BEAT) - August 4 at 12:23 PM logoBIOTELEMETRY, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:BEAT) - August 3 at 9:28 PM logoNotable movements of Stocks: BioTelemetry, Inc. (NASDAQ:BEAT) , NxStage Medical, Inc. (NASDAQ:NXTM) - Street Updates (NASDAQ:BEAT) - August 3 at 3:50 PM logoBioTelemetry Inc. : BioTelemetry, Inc. Reports Second Quarter 2016 Financial Results (NASDAQ:BEAT) - August 2 at 9:27 PM logoBioTelemetry posts 2Q profit (NASDAQ:BEAT) - August 2 at 9:27 PM logoEarnings Reaction History: BioTelemetry, Inc., 66.7% Follow-Through - Nasdaq (NASDAQ:BEAT) - August 2 at 3:47 PM logoQ2 2016 BioTelemetry Inc Earnings Release - After Market Close (NASDAQ:BEAT) - August 2 at 8:35 AM logoRecent Analysts Ratings of Stocks: BioTelemetry, Inc. (NASDAQ:BEAT) , Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Street Updates (NASDAQ:BEAT) - August 1 at 8:44 AM


BioTelemetry (NASDAQ:BEAT) Chart for Friday, October, 21, 2016

Last Updated on 10/21/2016 by Staff